249 related articles for article (PubMed ID: 33719215)
1. Hyperbaric oxygen treatment is associated with a decrease in cytokine levels in patients with necrotizing soft-tissue infection.
Hedetoft M; Garred P; Madsen MB; Hyldegaard O
Physiol Rep; 2021 Mar; 9(6):e14757. PubMed ID: 33719215
[TBL] [Abstract][Full Text] [Related]
2. Soluble ICAM-1 is modulated by hyperbaric oxygen treatment and correlates with disease severity and mortality in patients with necrotizing soft-tissue infection.
Hedetoft M; Moser C; Jensen PØ; Vinkel J; Hyldegaard O
J Appl Physiol (1985); 2021 Mar; 130(3):729-736. PubMed ID: 33444122
[TBL] [Abstract][Full Text] [Related]
3. Biomarkers of Necrotising Soft Tissue Infections Aspects of the Innate Immune Response.
Hansen MB
Dan Med J; 2017 Jul; 64(7):. PubMed ID: 28673381
[TBL] [Abstract][Full Text] [Related]
4. Hyperbaric oxygen treatment impacts oxidative stress markers in patients with necrotizing soft-tissue infection.
Hedetoft M; Jensen PØ; Moser C; Vinkel J; Hyldegaard O
J Investig Med; 2021 Oct; 69(7):1330-1338. PubMed ID: 34006573
[TBL] [Abstract][Full Text] [Related]
5. Hyperbaric oxygen treatment in the management of necrotising soft-tissue infections: results from a Danish nationwide registry study.
Hedetoft M; Madsen MB; Hyldegaard O
BMJ Open; 2023 Feb; 13(2):e066117. PubMed ID: 36813488
[TBL] [Abstract][Full Text] [Related]
6. Association between cytokine response, the LRINEC score and outcome in patients with necrotising soft tissue infection: a multicentre, prospective study.
Hansen MB; Rasmussen LS; Svensson M; Chakrakodi B; Bruun T; Madsen MB; Perner A; Garred P; Hyldegaard O; Norrby-Teglund A;
Sci Rep; 2017 Feb; 7():42179. PubMed ID: 28176831
[TBL] [Abstract][Full Text] [Related]
7. Key pathways and genes that are altered during treatment with hyperbaric oxygen in patients with sepsis due to necrotizing soft tissue infection (HBOmic study).
Vinkel J; Rib L; Buil A; Hedetoft M; Hyldegaard O
Eur J Med Res; 2023 Nov; 28(1):507. PubMed ID: 37946314
[TBL] [Abstract][Full Text] [Related]
8. Associations of Plasma Nitrite, L-Arginine and Asymmetric Dimethylarginine With Morbidity and Mortality in Patients With Necrotizing Soft Tissue Infections.
Hansen MB; Rasmussen LS; Garred P; Pilely K; Wahl AM; Perner A; Madsen MB; Hedegaard ER; Simonsen U; Hyldegaard O
Shock; 2018 Jun; 49(6):667-674. PubMed ID: 28863028
[TBL] [Abstract][Full Text] [Related]
9. Discriminatory plasma biomarkers predict specific clinical phenotypes of necrotizing soft-tissue infections.
Palma Medina LM; Rath E; Jahagirdar S; Bruun T; Madsen MB; Strålin K; Unge C; Hansen MB; Arnell P; Nekludov M; Hyldegaard O; Lourda M; Santos VAMD; Saccenti E; Skrede S; Svensson M; Norrby-Teglund A
J Clin Invest; 2021 Jul; 131(14):. PubMed ID: 34263738
[TBL] [Abstract][Full Text] [Related]
10. SuPAR correlates with mortality and clinical severity in patients with necrotizing soft-tissue infections: results from a prospective, observational cohort study.
Polzik P; Grøndal O; Tavenier J; Madsen MB; Andersen O; Hedetoft M; Hyldegaard O
Sci Rep; 2019 Mar; 9(1):5098. PubMed ID: 30911053
[TBL] [Abstract][Full Text] [Related]
11. Hyperbaric oxygenation therapy alleviates chronic constrictive injury-induced neuropathic pain and reduces tumor necrosis factor-alpha production.
Li F; Fang L; Huang S; Yang Z; Nandi J; Thomas S; Chen C; Camporesi E
Anesth Analg; 2011 Sep; 113(3):626-33. PubMed ID: 21596875
[TBL] [Abstract][Full Text] [Related]
12. Complement Activation Is Associated With Mortality in Patients With Necrotizing Soft-Tissue Infections-A Prospective Observational Study.
Kristensen MK; Hansen MB; Madsen MB; Hansen CB; Pilely K; Hyldegaard O; Garred P
Front Immunol; 2020; 11():17. PubMed ID: 32082310
[No Abstract] [Full Text] [Related]
13. Investigating the Effects of Hyperbaric Oxygen Treatment in Necrotizing Soft Tissue Infection With Transcriptomics and Machine Learning (the HBOmic Study): Protocol for a Prospective Cohort Study With Data Validation.
Vinkel J; Rib L; Buil A; Hedetoft M; Hyldegaard O
JMIR Res Protoc; 2022 Nov; 11(11):e39252. PubMed ID: 36427229
[TBL] [Abstract][Full Text] [Related]
14. A prospective, randomized clinical trial to compare the effect of hyperbaric to normobaric hyperoxia on cerebral metabolism, intracranial pressure, and oxygen toxicity in severe traumatic brain injury.
Rockswold SB; Rockswold GL; Zaun DA; Zhang X; Cerra CE; Bergman TA; Liu J
J Neurosurg; 2010 May; 112(5):1080-94. PubMed ID: 19852540
[TBL] [Abstract][Full Text] [Related]
15. Associations between YKL-40 and markers of disease severity and death in patients with necrotizing soft-tissue infection.
Hedetoft M; Hansen MB; Madsen MB; Johansen JS; Hyldegaard O
BMC Infect Dis; 2021 Oct; 21(1):1046. PubMed ID: 34627195
[TBL] [Abstract][Full Text] [Related]
16. Hyperbaric oxygen treatment and survival from necrotizing soft tissue infection.
Wilkinson D; Doolette D
Arch Surg; 2004 Dec; 139(12):1339-45. PubMed ID: 15611459
[TBL] [Abstract][Full Text] [Related]
17. Hyperbaric oxygen therapy as an adjuvant to source control in necrotizing soft tissue infections.
Ferreira APP; Vide SS; Fernandes TDF; Coelho PMBS; Camacho ÓF
Undersea Hyperb Med; 2017; 44(6):535-542. PubMed ID: 29281190
[TBL] [Abstract][Full Text] [Related]
18. Interventions for necrotizing soft tissue infections in adults.
Hua C; Bosc R; Sbidian E; De Prost N; Hughes C; Jabre P; Chosidow O; Le Cleach L
Cochrane Database Syst Rev; 2018 May; 5(5):CD011680. PubMed ID: 29851032
[TBL] [Abstract][Full Text] [Related]
19. Increase in the Complement Activation Product C4d and the Terminal Complement Complex sC5b-9 Is Associated with Disease Severity and a Fatal Outcome in Necrotizing Soft-Tissue Infection.
Hedetoft M; Madsen MB; Hansen CB; Hyldegaard O; Garred P
J Innate Immun; 2022; 14(4):355-365. PubMed ID: 34903692
[TBL] [Abstract][Full Text] [Related]
20. Biomarkers of necrotising soft tissue infections: aspects of the innate immune response and effects of hyperbaric oxygenation-the protocol of the prospective cohort BIONEC study.
Hansen MB; Simonsen U; Garred P; Hyldegaard O
BMJ Open; 2015 May; 5(5):e006995. PubMed ID: 25967993
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
